| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
40,080,000 |
| Market
Cap: |
16.04(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.4002 - $0.4002 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases. Co.'s business segments are: Specialized BioTherapeutics, which is developing and moving toward potential commercialization of HyBryte™, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma; and Public Health Solutions, which includes development programs for RiVax®, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic resistant and other infectious disease and its vaccine programs targeting filoviruses and CiVax™, its vaccine candidate for the prevention of COVID-19.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
28,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$12,866 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cote Timothy R. |
|
– • – |
2023-05-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,317 |
|
- |
|
| Straube Richard |
SENIOR VICE PRESIDENT AND CMO |
• – – |
2022-05-18 |
4 |
B |
$0.50 |
$4,000 |
D/D |
8,000 |
8,000 |
0.01 |
9% |
|
| Schaber Christopher |
CHAIRMAN, CEO AND PRESIDENT |
• • – |
2022-05-18 |
4 |
B |
$0.44 |
$8,866 |
D/D |
20,000 |
90,095 |
0.01 |
9% |
|
| Schaber Christopher |
CHAIRMAN, CEO AND PRESIDENT |
• • – |
2021-12-17 |
4 |
B |
$0.74 |
$5,179 |
D/D |
7,000 |
70,095 |
0.01 |
-29% |
|
| Guarino Jonathan L. |
Senior Vice President and CFO |
• – – |
2021-12-15 |
4 |
B |
$0.70 |
$700 |
D/D |
1,000 |
11,000 |
2.66 |
-30% |
|
| Guarino Jonathan L. |
Senior Vice President and CFO |
• – – |
2021-12-14 |
4 |
B |
$0.71 |
$7,119 |
D/D |
10,000 |
10,000 |
2.74 |
-27% |
|
| Schaber Christopher |
Chairman, CEO and President |
• • – |
2021-12-14 |
4 |
B |
$0.73 |
$7,269 |
D/D |
10,000 |
63,095 |
2.81 |
-27% |
|
| Zeldis Jerome B |
Director |
– • – |
2021-05-14 |
4 |
S |
$0.90 |
$2,701 |
D/D |
(3,000) |
22,917 |
|
-17% |
|
| Zeldis Jerome B |
Director |
– • – |
2021-05-14 |
4 |
B |
$0.89 |
$2,664 |
D/D |
3,000 |
25,917 |
2.31 |
17% |
|
| Zeldis Jerome B |
Director |
– • – |
2019-11-19 |
4 |
B |
$0.93 |
$1,850 |
D/D |
2,000 |
22,917 |
2.31 |
- |
|
| Schaber Christopher |
Chairman, CEO and President |
• • – |
2019-11-19 |
4 |
B |
$0.93 |
$10,016 |
D/D |
10,770 |
53,095 |
2.81 |
- |
|
| Parks Diane L. |
Director |
– • – |
2019-09-23 |
4 |
B |
$0.93 |
$13,870 |
D/D |
14,940 |
14,940 |
2.39 |
- |
|
| Zeldis Jerome B |
Director |
– • – |
2019-09-19 |
4 |
B |
$0.94 |
$3,740 |
D/D |
4,000 |
20,917 |
2.31 |
- |
|
| Pearson Mark E. |
Director |
– • • |
2019-06-28 |
4 |
A |
$0.71 |
$55,620 |
I/I |
78,338 |
78,338 |
|
- |
|
| Schaber Christopher |
Chairman, CEO and President |
• • – |
2018-10-18 |
4 |
B |
$1.17 |
$10,177 |
D/D |
8,700 |
37,325 |
2.81 |
- |
|
| Pearson Mark E. |
Director |
– • – |
2018-10-17 |
4 |
B |
$1.16 |
$197,200 |
D/D |
170,000 |
2,500,000 |
2.39 |
- |
|
| Schaber Christopher |
Chairman, CEO and President |
• • – |
2018-08-22 |
4 |
B |
$1.42 |
$5,012 |
D/D |
3,530 |
28,625 |
2.81 |
- |
|
| Cavazza Preta Martina |
Former 10% Owner |
– – – |
2017-11-29 |
4 |
B |
$2.12 |
$622,241 |
D/D |
293,510 |
293,510 |
2.44 |
- |
|
| Cavazza Preta Martina |
Former 10% Owner |
– – – |
2017-11-29 |
4 |
S |
$2.12 |
$622,241 |
I/I |
(293,510) |
0 |
|
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2017-05-08 |
4 |
S |
$2.54 |
$29,403 |
I/I |
(11,576) |
85,397 |
|
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2017-05-05 |
4 |
S |
$2.70 |
$230,850 |
I/I |
(85,500) |
87,278 |
|
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2017-05-04 |
4 |
S |
$2.97 |
$241,629 |
I/I |
(63,892) |
101,171 |
|
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2017-05-04 |
4 |
OE |
$0.80 |
$200,000 |
I/I |
250,000 |
583,334 |
|
- |
|
| Schaber Christopher |
Chairman, CEO and President |
• • – |
2016-12-16 |
4 |
B |
$3.16 |
$49,939 |
D/D |
15,804 |
25,095 |
2.81 |
- |
|
| Rubin Robert Joseph |
Director |
– • – |
2016-12-16 |
4 |
B |
$3.16 |
$10,001 |
D/D |
3,165 |
4,385 |
2.39 |
- |
|
39 Records found
|
|
Page 1 of 2 |
|
|
